Assess whether to re-trade, restructure, or drop (ea3fa6)

SITUATION In a public acquirer facing HSR and sector regulators, regulatory-approval critical-path calendar is the evidence after an earnout based on 'adjusted EBITDA' with no dictionary. Customer-contract risk reviewer has to pick To re-trade, restructure, or Drop for this M&A Due Diligence People and Contracts close using regulatory-approval critical-path calendar.

DECISION Customer-contract risk reviewer in a public acquirer facing HSR and sector regulators must choose To re-trade, restructure, / Drop using regulatory-approval critical-path calendar after an earnout based on 'adjusted EBITDA' with no dictionary.

HYPOTHESES TO TEST 1. An earnout based on 'adjusted EBITDA' with no dictionary is noise around an already-controlled People and Contracts process in a public acquirer facing HSR and sector regulators, given regulatory-approval critical-path calendar. 2. An earnout based on 'adjusted EBITDA' with no dictionary is the event in regulatory-approval critical-path calendar that forces To re-trade, restructure, for customer-contract risk reviewer under M&A Due Diligence. 3. Regulatory-approval critical-path calendar shows a one-file miss after an earnout based on 'adjusted EBITDA' with no dictionary, not a People and Contracts program failure. 4. Regulatory-approval critical-path calendar cannot decide to re-trade, restructure, or drop yet after an earnout based on 'adjusted EBITDA' with no dictionary; hold is the only M&A Due Diligence close a public acquirer facing HSR and sector regulators can defend.

ANALYSIS REQUIRED 1. Test whether an earnout based on 'adjusted EBITDA' with no dictionary is a diligence gap, a price chip, or a walk-away. 2. Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar. 3. Map reps, earnout mechanics, and integration risk a public acquirer facing HSR and sector regulators would inherit. 4. For this M&A Due Diligence People and Contracts file, read regulatory-approval critical-path calendar against an earnout based on 'adjusted EBITDA' with no dictionary and write the one fact that would move to re-trade, restructure, or drop for customer-contract risk reviewer.

RECOMMENDATION Choose To re-trade, restructure, / Drop on this M&A Due Diligence / People and Contracts packet (regulatory-approval critical-path calendar after an earnout based on 'adjusted EBITDA' with no dictionary). Lead with the M&A Due Diligence option regulatory-approval critical-path calendar can support after an earnout based on 'adjusted EBITDA' with no dictionary, then the two facts that force it, then the Monday action for customer-contract risk reviewer in a public acquirer facing HSR and sector regulators.